Video Experimental Relacionado
Updated: May 11, 2026
08:28
Experimental Metastasis Assay
Published on: August 25, 2010
Resumen
El tratamiento con N-metil-N'-nitronitrosoguanidina (MNNG) activó el metoncogén en las células de sarcoma osteogénico humano. Esto implicó una fusión de los loci met y tpr, creando una nueva transcripción híbrida y activando la familia de genes de la tirosina quinasa.
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Genética La genética.
Sus antecedentes:
- El oncogén met, parte de la familia de genes de la tirosina quinasa, juega un papel en varios tipos de cáncer.
- Comprender los mecanismos de activación de los oncogenes es crucial para el desarrollo de terapias dirigidas contra el cáncer.
Objetivo del estudio:
- Para investigar la activación in vitro del oncogén met en una línea celular de sarcoma osteogénico humano (HOS) utilizando N-metil-N itrosonitrosoguanidina (MNNG).
- Para caracterizar las alteraciones genéticas y las transcripciones resultantes asociadas con la activación de met oncogenes.
Principales métodos:
- Tratamiento de las células HOS con MNNG, un conocido carcinógeno clastogénico.
- Análisis de la expresión génica utilizando sondas para el locus oncogénico encontrado.
- Identificación y caracterización de transcripciones de ARN, incluidas las transcripciones híbridas.
Principales resultados:
- El tratamiento con MNNG indujo la activación del oncogén met en las células HOS.
- Se reconocieron dos transcripciones distintas (9.0 kb y 10.0 kb) del locus met oncogene.
- Se detectó una nueva transcripción de ARN híbrido de 5.0 kb, resultante de la fusión del tpr y el loci. proto-oncogeno met.
- El locus tpr, asociado con el ARN de 10,0 kb, se asigna al cromosoma 1, mientras que el locus proto-oncogénico met se asigna al cromosoma 7q21-31.
Conclusiones:
- La activación del oncogén met en las células HOS implica la fusión de los loci met y tpr cromosómicamente dispares.
- Este evento de fusión genera una nueva transcripción híbrida, lo que lleva a la activación del metoncogén y su actividad asociada de tirosina quinasa.
- Los hallazgos proporcionan información sobre el mecanismo de activación de oncogenes a través de reordenamientos cromosómicos.
Videos de Conceptos Relacionados
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...